All That Glitters Is Not Gold: The Story of Rovalpituzumab Tesirine in SCLC

Dipesh Uprety; Jordi Remon; Alex A. Adjei

doi:10.1016/j.jtho.2021.07.012

All That Glitters Is Not Gold: The Story of Rovalpituzumab Tesirine in SCLC

Dipesh Uprety, Jordi Remon, Alex A. Adjei

Medical Oncology

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1429-1433
Number of pages	5
Journal	Journal of Thoracic Oncology
Volume	16
Issue number	9
DOIs	https://doi.org/10.1016/j.jtho.2021.07.012
State	Published - Sep 2021

ASJC Scopus subject areas

Oncology
Pulmonary and Respiratory Medicine

Access to Document

10.1016/j.jtho.2021.07.012

Cite this

@article{db63ccada5944c9aafaca204bda5b143,

title = "All That Glitters Is Not Gold: The Story of Rovalpituzumab Tesirine in SCLC",

author = "Dipesh Uprety and Jordi Remon and Adjei, {Alex A.}",

note = "Funding Information: Disclosure: Dr. Remon reports receiving support from Merck Sharp & Dohme, Boehringer, and Pfizer; personal fees and other support from OSE Immunotherapeutics; and other support from Bristol-Myers Squibb, AstraZeneca, Roche, and Bayer outside of the submitted work. The remaining authors declare no conflict of interest.",

year = "2021",

month = sep,

doi = "10.1016/j.jtho.2021.07.012",

language = "English (US)",

volume = "16",

pages = "1429--1433",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "International Association for the Study of Lung Cancer",

number = "9",

}

TY - JOUR

T1 - All That Glitters Is Not Gold

T2 - The Story of Rovalpituzumab Tesirine in SCLC

AU - Uprety, Dipesh

AU - Remon, Jordi

AU - Adjei, Alex A.

N1 - Funding Information: Disclosure: Dr. Remon reports receiving support from Merck Sharp & Dohme, Boehringer, and Pfizer; personal fees and other support from OSE Immunotherapeutics; and other support from Bristol-Myers Squibb, AstraZeneca, Roche, and Bayer outside of the submitted work. The remaining authors declare no conflict of interest.

PY - 2021/9

Y1 - 2021/9

UR - http://www.scopus.com/inward/record.url?scp=85113603171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85113603171&partnerID=8YFLogxK

U2 - 10.1016/j.jtho.2021.07.012

DO - 10.1016/j.jtho.2021.07.012

M3 - Editorial

C2 - 34425994

AN - SCOPUS:85113603171

SN - 1556-0864

VL - 16

SP - 1429

EP - 1433

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 9

ER -

All That Glitters Is Not Gold: The Story of Rovalpituzumab Tesirine in SCLC

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this